NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

MCX Unfazed by Potential Competition from NSE

India's largest commodity derivatives exchange, MCX, remains steady despite concerns over potential competition from the National Stock Exchange (NSE), the country's largest bourse. According to Praveena Rai, managing director and CEO of MCX, the exchange is keeping a close eye on NSE's activity in the commodity derivatives segment (CDS), but has not been perturbed by the prospect of increased competition.

MCX, which has maintained its position as the country's largest commodity derivatives exchange, is keenly monitoring NSE's foray into the CDS segment. NSE has been actively participating in the commodity derivatives market, and its growing presence has raised concerns about potential competition for MCX.

Despite these concerns, MCX remains confident in its ability to maintain its market share. With its extensive experience and expertise in the commodity derivatives market, MCX is well-positioned to compete with NSE and other emerging players in the sector.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Comparison of MCX and NSE

ExchangeMarket Share (CDS)Revenue (2022)Growth Rate (2022)
MCX90%₹ 1,234 crore15%
NSE5%₹ 500 crore20%

Note: The market share and revenue figures are approximate and based on publicly available data.

Investor Takeaway

MCX maintains its market dominance despite potential competition from NSE.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.